Coverage
-
March 01, 2022
A Texas federal judge has tossed Canopy Growth Corp.'s claims against GW Pharmaceuticals PLC units for allegedly infringing its patented extraction process to make the flagship CBD drug Epidiolex, after the parties agreed that Canopy couldn't prevail on the issue of infringement.
2 other articles on this case.
View all »